Recent Funding
Investors
GlaxoSmithKline

GlaxoSmithKline

GlaxoSmithKline has backed 1 company on Recent Funding, 1 in the last 12 months; its most recent deal is LifeMine Therapeutics (2026-08-06).

TypeInvestor

Portfolio on Recent Funding1

Deals, last 12 months1

Capital in their rounds$75M

What GlaxoSmithKline invests in

Health and bio · 1 · 100%

How GlaxoSmithKline invests

Stage	Deals	Capital in rounds
Series B+	1 100%	$75M

Share is of the 1 round on Recent Funding that name GlaxoSmithKline. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio

Company	Round with GlaxoSmithKline	Total raised	Latest raise
LLifeMine Therapeutics Health and bio	Aug 6, 2026 Series B+ · $75M	$543M	Aug 6, 2026 Series B+

Most frequent co-investors

GGV1 shared round · last Aug 6, 2026
BBezos Expeditions1 shared round · last Aug 6, 2026
GGates Frontier1 shared round · last Aug 6, 2026
IInvus1 shared round · last Aug 6, 2026
AARCH Venture Partners1 shared round · last Aug 6, 2026
MMilky Way Investments1 shared round · last Aug 6, 2026
RRA Capital Management1 shared round · last Aug 6, 2026
LLoLa Capital Partners1 shared round · last Aug 6, 2026

Portfolio companies are the companies on Recent Funding with a round that lists GlaxoSmithKline, which is a subset of its real portfolio. API: /api/v1/investors/glaxosmithkline. All investors.